Palo Alto Networks, Inc. (NASDAQ:PANW – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the forty-two analysts that are covering the company, Marketbeat Ratings reports.
Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...
In a report released yesterday, Conor McNamara from RBC Capital maintained a Buy rating on Illumina (ILMN – Research Report), with a price ...
In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on 908 Devices (MASS – Research Report), with a ...
AbbVie, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, and Illumina are the five Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks represent ...
Major indices closed higher on Wednesday after Commerce Secretary Howard Lutnick said that the US might meet Canada and ...
Wall Street trading got off to a mixed start on Wednesday after Commerce Secretary Howard Lutnick said that the US might meet ...
Illumina said at the time that it was working to find a solution. “We respect and abide by Chinese laws and regulations,” the ...
Electric-vehicle maker Tesla and traditional car companies such as General Motors fall as tariffs on Canada, Mexico, and ...
China announced a ban on Tuesday on imports of genetic sequencers from San Diego medical equipment maker Illumina, just minutes after U.S. President Donald Trump's additional 10% tariff on Chinese ...
China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...
After a solid January, the S&P 500 stumbled in February on concerns about slowing economic growth and a growing trade war. [ Sign up for stock news with our Invested newsletter.] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results